Status:
RECRUITING
Assessment of Kidney Function by Electrical Impedance Tomography (EIT)
Lead Sponsor:
The University of Hong Kong
Conditions:
Chronic Kidney Diseases
Eligibility:
All Genders
18-90 years
Brief Summary
The product under investigation is named Gense EIT-kidney device. This kidney device is a portable and non-invasive imaging modality capable of capturing the cross-sectional bioelectrical impedance di...
Detailed Description
Chronic kidney disease (CKD) is an escalating health problem in the global and local perspective. CKD is defined as all disorders affecting kidney structures and functions. The main classifications ar...
Eligibility Criteria
Inclusion
- \- clinically diagnosed with CKD at different stages (stage 1-5) of the disease based on GFR measurement results Age: 18-90. Gender: Male/ Female
Exclusion
- ● Subjects with known kidney disease or abnormalities (for the control group).
- Subjects who had any kind of kidney surgery or kidney transplantation.
- Subjects with damaged skin on the abdomen.
- Subjects with implanted electronic devices.
- Subjects with spinal diseases/discomfort
- Subjects who had any recent abdominal surgery
- Pregnant women.
- Obese subjects (BMI\>35).
- Subjects with uncontrollable involuntary body movements such as degenerative disorders (e.g., Alzheimer's and Parkinson's disease); Seizure disorders (e.g., epilepsy, stroke, neuroleptic drugs); Neurological disorders (e.g., tardive dyskinesia and cerebral palsy, tremors, myoclonus, tics, athetosis, etc.)
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT06898294
Start Date
September 1 2021
End Date
August 31 2025
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital, Hong Kong
Hong Kong, Hong Kong